Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 13 Sponsors

Apr 28, 2026 · House

Author added Repinski

Apr 16, 2026 · House

Author added Baker

Mar 25, 2026 · House

Author stricken Schomacker

Mar 23, 2026 · House

Motion to recall and re-refer, motion did not prevail Commerce Finance and Policy

Mar 18, 2026 · House

Author added Keeler

Mar 16, 2026 · House

Author added Anderson, P. H.

Mar 12, 2026 · House

Author stricken Perryman

Mar 12, 2026 · House

Authors added Warwas, Skraba, and Davis

Mar 5, 2026 · House

Author added Gander

Mar 2, 2026 · House

Author added Rehrauer

Feb 26, 2026 · House

Authors added Norris, Johnson, P., and Swedzinski

Feb 25, 2026 · House

Author stricken Gillman

Feb 23, 2026 · House

Introduction and first reading, referred to Health Finance and Policy

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 2%, measured from MN's completed sessions
Momentum base 50/100 from the pace of recorded action
Time since last action -22 165 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.